Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-21-032361

Chief Medical Officer sold 1,000 shares at $50.15 ($50,150)

  • Chief Medical Officer acquired 1,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ordonez Claudia Chief Medical Officer 2021-05-11 Option exercise +1,000 $0.48 $480 1,000 D
Ordonez Claudia Chief Medical Officer 2021-05-11 Sale −1,000 $50.15 $50,150 0 D
Derivatives
Ordonez Claudia Chief Medical Officer 2021-05-11 Option exercise · Employee Stock Option (right to buy) −1,000 99,211 D
Open-market sales · 1,000 sh · avg $50.15 · $50,150
Loading xslF345X03/doc4.xml…